A Phase II Study of High-Dose Cetuximab plus Irinotecan in Colorectal Cancer Patients with KRAS Wild-Type Tumors Who Progressed after Standard Dose of Cetuximab plus Irinotecan

Ahmad A. Fora, Jeanne A. McMahon, Greg Wilding, Adrienne Groman, Wen Wee Ma, Karen S. Romano, Marwan G. Fakih

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of High-Dose Cetuximab plus Irinotecan in Colorectal Cancer Patients with KRAS Wild-Type Tumors Who Progressed after Standard Dose of Cetuximab plus Irinotecan'. Together they form a unique fingerprint.

Medicine & Life Sciences